Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine and Valproic Acid Maintenance Post-Transplant for AML/MDS
NCT02124174Phase 2Unknown
- Start
- Jan 2012
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS). Status: unknown.
02
Drugs
valproic acid
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT02124174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02124174.